CRFR
Read More about this categoryShow Less
CRFR (Corticotropin-releasing Factor Receptor), also known as corticotropin-releasing hormone receptor (CRHR), belongs to the G protein-coupled receptor family. There are 3 types of this recetpor, CRF1, CRF2 and CRF3 receptor. CRF1 receptor (CRF1 or CRF1α) is functionally coupled to adenylate cyclase and it belongs to the secretin-like, family B of GPCRs. CRF1 receptor has several splice variants (CRF1c-CRF1m) including CRF1β. CRF2 receptor is a 411-amino acid protein with approximately 70% identity to the known CRF1 and it is functionally coupled to adenylate cyclase. The CRF2 receptor has been shown to be expressed as three functional splice variants, the CRF2α (411-413 amino acids), the CRF2β (431-438 amino acids) and the CRF2γ (397 amino acids). CRF3 receptor is a 428-amino acid protein, which binds CRF with a 5-fold higher affinity than URO and SVG and is expressed in the pituitary gland, urophysis, and brain.
CRFR subserves central functions related to stress physiology, and also exerts peripheral actions relevant to cardiovascular, muscular, gastrointestinal, pancreatic, inflammatory, and neoplastic diseases.
Products Related to CRFR(27)
- GC19374VerucerfontCAS: 885220-61-1Purity: >99.00%
Verucerfont is a corticotropin-releasing factor receptor 1 (CRF1) antagonist with IC50s of ~6.1, >1000 and >1000 nM for CRF1, CRF2, and CRF-BP, respectively.
- GC30792R121919 (NBI30775)CAS: 195055-03-9Purity: >98.00%
R121919 (NBI30775) (NBI30775) is a potent small-molecule CRF1 receptor antagonist with a Ki of 2 to 5 nM for the CRF1 receptor and over 1000-fold weaker activity at the CRF2 receptor, CRF-binding protein, or 70 other receptor types.
- GC30863CP 376395 (CP-316311)CAS: 175140-00-8Purity: >99.50%
CP 376395 (CP-316311) is a potent and selective Corticotropin releasing factor 1 (CRF1) receptor antagonist.
- GC31166Emicerfont (GW876008)CAS: 786701-13-1Purity: >98%
Emicerfont (GW876008) is a corticotropin-releasing factor type 1 (CRF1) receptor antagonist with an IC50 of 66 nM.
- GC32590Urotensin I (Catostomus urotensin I)CAS: 83930-33-0Purity: >98%
Urotensin I (Catostomus urotensin I) (Catostomus urotensin I), a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively.
- GC33712Pexacerfont (BMS-562086)CAS: 459856-18-9Purity: >99.50%
Pexacerfont (BMS-562086) is a selective corticotropin-releasing factor (CRF1) receptor antagonist with IC50 of 6.1±0.6 nM for human CRF1 receptor.
- GC34542CRF, bovine TFAPurity: >98%
CRF, bovine (TFA) is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM.
- GC35748CRF, bovineCAS: 92307-52-3Purity: >98.00%
CRF, bovine is an important neuropeptide consisting of 41 amino acids, it is produced by the hypothalamus and is transported to the pituitary, where it triggers the release of adrenocorticotropic hormone (ACTH).
- GC37868Urocortin II, humanCAS: 351999-18-3Purity: >99.5%
Urocortin II (human) is a selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor.
- GC37869Urocortin III, mouseCAS: 357952-10-4Purity: >98%
Urocortin III, mouse is a corticotropin-releasing factor (CRF)-related peptide.
- GC38886Antisauvagine-30 TFAPurity: >98.00%
Antisauvagine-30 TFA (aSvg-30 TFA) is a potent, highly selective and competitive CRF2 receptor peptidic antagonist.
- GC60724Corticotropin-releasing factor (human) (acetate)Purity: >98.50%
Corticotropin-releasing factor human acetate (Human CRF acetate) stimulates the synthesis and secretion of adrenocorticotropin in the anterior pituitary.
- GC61583Urotensin I TFAPurity: >98.00%
Urotensin I (Catostomus urotensin I) TFA, a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively.
- GC65893TildacerfontCAS: 1014983-00-6Purity: >98%
Tildacerfont is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia.
- GC66088α-Helical CRF(9-41) TFAPurity: >99.00%
α-Helical CRF(9-41) TFA is a competitive CRF2 receptor antagonist with KB of ~100 nM. α-Helical CRF(9-41) TFA is also a partial agonist of CRF1 receptor with an EC50 of 140 nM.
- GC70559AntalarminCAS: 157284-96-3Purity: >97.00%
Antalarmin, a pyrrolopyrimidine, is a potent, small molecule, nonpeptide CRF1 (Corticotropin-Releasing Factor Receptor 1) selective receptor antagonist.
- GC72120Stressin I TFAPurity: >98.00%
Stressin I (Cyclo(31-34)[DPhe12,Nle21,38,Glu31,Lys34]Ac-hCRF(4-41)) TFA is a potent CRF1 receptor selective agonist, Ki is 1.7 nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC12802 | Urocortin (rat) | 171543-83-2 | >98% | |
Endogenous CRF agonist | ||||
| GC17432 | Urocortin (human) | 176591-49-4 | >98.00% | |
Endogenous CRF agonist | ||||
| GC19374 | Verucerfont | 885220-61-1 | >99.00% | |
Verucerfont is a corticotropin-releasing factor receptor 1 (CRF1) antagonist with IC50s of ~6.1, >1000 and >1000 nM for CRF1, CRF2, and CRF-BP, respectively. | ||||
| GC30792 | R121919 (NBI30775) | 195055-03-9 | >98.00% | |
R121919 (NBI30775) (NBI30775) is a potent small-molecule CRF1 receptor antagonist with a Ki of 2 to 5 nM for the CRF1 receptor and over 1000-fold weaker activity at the CRF2 receptor, CRF-binding protein, or 70 other receptor types. | ||||
| GC30863 | CP 376395 (CP-316311) | 175140-00-8 | >99.50% | |
CP 376395 (CP-316311) is a potent and selective Corticotropin releasing factor 1 (CRF1) receptor antagonist. | ||||
| GC31030 | DMP 696 | 202578-52-7 | >99.00% | |
DMP 696 is a selective corticotropin-releasing hormone receptor 1 (CRHR1) antagonist. | ||||
| GC31043 | CP 316311 | 175139-41-0 | >98% | |
CP 316311 is a potent and selective CRF1 receptor antagonist with an IC50 value of 6.8 nM. | ||||
| GC31166 | Emicerfont (GW876008) | 786701-13-1 | >98% | |
Emicerfont (GW876008) is a corticotropin-releasing factor type 1 (CRF1) receptor antagonist with an IC50 of 66 nM. | ||||
| GC32590 | Urotensin I (Catostomus urotensin I) | 83930-33-0 | >98% | |
Urotensin I (Catostomus urotensin I) (Catostomus urotensin I), a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively. | ||||
| GC33712 | Pexacerfont (BMS-562086) | 459856-18-9 | >99.50% | |
Pexacerfont (BMS-562086) is a selective corticotropin-releasing factor (CRF1) receptor antagonist with IC50 of 6.1±0.6 nM for human CRF1 receptor. | ||||
| GC34542 | CRF, bovine TFA | - | >98% | |
CRF, bovine (TFA) is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM. | ||||
| GC35748 | CRF, bovine | 92307-52-3 | >98.00% | |
CRF, bovine is an important neuropeptide consisting of 41 amino acids, it is produced by the hypothalamus and is transported to the pituitary, where it triggers the release of adrenocorticotropic hormone (ACTH). | ||||
| GC36787 | NVS-CRF38 | 1207258-55-6 | >98% | |
NVS-CRF38 is a novel corticotropin-releasing factor receptor 1 (CRF1) antagonist with low water solubility. | ||||
| GC37868 | Urocortin II, human | 351999-18-3 | >99.5% | |
Urocortin II (human) is a selective endogenous peptide agonist of type-2 corticotropin-releasing factor (CRF2) receptor. | ||||
| GC37869 | Urocortin III, mouse | 357952-10-4 | >98% | |
Urocortin III, mouse is a corticotropin-releasing factor (CRF)-related peptide. | ||||
| GC37870 | Urocortin III, mouse (TFA) | - | >99.50% | |
| GC38886 | Antisauvagine-30 TFA | - | >98.00% | |
Antisauvagine-30 TFA (aSvg-30 TFA) is a potent, highly selective and competitive CRF2 receptor peptidic antagonist. | ||||
| GC50455 | Cortagine | - | >98% | |
Cortagine is a kind of corticotropin-releasing factor receptor subtype 1 (CRF1) peptidic agonist, with an IC 50 of 2.6nM and an EC 50 of 0.47nM for rCRF1. | ||||
| GC60724 | Corticotropin-releasing factor (human) (acetate) | - | >98.50% | |
Corticotropin-releasing factor human acetate (Human CRF acetate) stimulates the synthesis and secretion of adrenocorticotropin in the anterior pituitary. | ||||
| GC61583 | Urotensin I TFA | - | >98.00% | |
Urotensin I (Catostomus urotensin I) TFA, a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively. | ||||
| GC65893 | Tildacerfont | 1014983-00-6 | >98% | |
Tildacerfont is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia. | ||||
| GC66088 | α-Helical CRF(9-41) TFA | - | >99.00% | |
α-Helical CRF(9-41) TFA is a competitive CRF2 receptor antagonist with KB of ~100 nM. α-Helical CRF(9-41) TFA is also a partial agonist of CRF1 receptor with an EC50 of 140 nM. | ||||
| GC70559 | Antalarmin | 157284-96-3 | >97.00% | |
Antalarmin, a pyrrolopyrimidine, is a potent, small molecule, nonpeptide CRF1 (Corticotropin-Releasing Factor Receptor 1) selective receptor antagonist. | ||||
| GC72120 | Stressin I TFA | - | >98.00% | |
Stressin I (Cyclo(31-34)[DPhe12,Nle21,38,Glu31,Lys34]Ac-hCRF(4-41)) TFA is a potent CRF1 receptor selective agonist, Ki is 1.7 nM. | ||||
